ArticleAmerican heart journal plus : cardiology research and practice2026
Beyond the 30-day metric: National trends and predictors of 90-day readmission after coronary artery bypass grafting.
Article in American heart journal plus : cardiology research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Study objective: Evaluate the national burden, predictors, and causes of 90-day readmission following coronary artery bypass grafting (CABG), and to examine temporal trends and demographic disparities in readmission risk. Design: Retrospective cohort study. Setting: United States hospitals participating in the Nationwide Readmissions Database. Participants: Adult patients (≥18 years) undergoing isolated CABG between 2016 and 2022 were identified using ICD-10 codes. Patients who died during the index hospitalization, underwent concomitant valve surgery were excluded. Main outcome measures: The primary outcome was all-cause 90-day readmission. Secondary outcomes included 30-day readmission, in-hospital complications, and causes of 90-day readmission. Results: Among 681,833 patients undergoing isolated CABG, 111,024 (16.3%) were readmitted within 90 days; notably, 36% occurred between 31 and 90 days after discharge. Heart failure was the leading cause of readmission (13.6%), followed by infection (6.7%), coronary artery disease-related diagnoses (6.7%), and atrial fibrillation (4.1%). Readmitted patients had higher rates of perioperative complications, including acute renal failure (28% vs 17%), respiratory failure (26% vs 17%), pneumonia (7% vs 3%), and transfusion (18% vs 12%). Independent predictors included female sex (adjusted odds ratio [aOR] 1.38), age ≥ 85 years (aOR 1.27), congestive heart failure (aOR 1.46), diabetes with complications (aOR 1.38), peripheral vascular disease (aOR 1.39), chronic kidney disease (aOR 1.30), and chronic obstructive pulmonary disease (aOR 1.34). Risk-adjusted readmission rates remained consistently higher among women across all age groups, with age-related patterns differing by sex. Conclusion: Our findings suggest that reliance on 30-day metrics may underestimate postoperative morbidity and highlight opportunities for extended post-discharge surveillance and complication prevention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.